Michelle A. Detry

9.1k total citations · 3 hit papers
45 papers, 2.7k citations indexed

About

Michelle A. Detry is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Michelle A. Detry has authored 45 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Oncology. Recurrent topics in Michelle A. Detry's work include Chronic Lymphocytic Leukemia Research (6 papers), Receptor Mechanisms and Signaling (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Michelle A. Detry is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Receptor Mechanisms and Signaling (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Michelle A. Detry collaborates with scholars based in United States, United Kingdom and Germany. Michelle A. Detry's co-authors include Yan Ma, Ashish M. Kamat, Jacqueline Wiltshire, Earlise Ward, Susan O’Brien, Michael J. Keating, Hagop M. Kantarjian, Stefan Faderl, William G. Wierda and Jörge E. Cortes and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Michelle A. Detry

44 papers receiving 2.6k citations

Hit Papers

Early Results of a Chemoimmunotherapy Regimen of Fludarab... 2005 2026 2012 2019 2005 2016 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
    2005 704 citations Michelle A. Detry et al. Journal of Clinical Oncology profile →
  2. Analyzing Repeated Measurements Using Mixed Models
    2016 279 citations Michelle A. Detry et al. profile →
  3. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
    2021 180 citations Benjamin R. Saville, Michelle A. Detry et al. profile →

Peers

Michelle A. Detry
Alexandros A. Drosos Greece
Ching‐Chi Chi Taiwan
Allan Gibofsky United States
Pekka Hannonen Finland
Paraskevi V. Voulgari Greece
César Ramos-Remus Mexico
Carol Hitchon Canada
Grzegorz Mazur Poland
Jill Waalen United States
M. H. van Rijswijk Netherlands
Alexandros A. Drosos Greece
Michelle A. Detry
Citations per year, relative to Michelle A. Detry Michelle A. Detry (= 1×) peers Alexandros A. Drosos

Countries citing papers authored by Michelle A. Detry

Since Specialization
Citations

This map shows the geographic impact of Michelle A. Detry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Detry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Detry more than expected).

Fields of papers citing papers by Michelle A. Detry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Detry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Detry. The network helps show where Michelle A. Detry may publish in the future.

Co-authorship network of co-authors of Michelle A. Detry

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Detry. A scholar is included among the top collaborators of Michelle A. Detry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Detry. Michelle A. Detry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picozzi, Vincent J., Anna M. Varghese, Paul E. Oberstein, et al.. (2025). Pamrevlumab plus nab-paclitaxel/gemcitabine (Pam + GA) as first- and second-line therapy in metastatic pancreatic cancer (mPDAC): Results from Precision Promise (PrP) Bayesian platform trial.. Journal of Clinical Oncology. 43(4_suppl). 673–673. 1 indexed citations
2.
Oberstein, Paul E., Andrea Wang‐Gillam, Anna M. Varghese, et al.. (2024). Precision Promise (PrP) Bayesian platform trial for metastatic pancreatic cancer (mPDAC): Results of the first experimental arm, SM-88 as second line therapy.. Journal of Clinical Oncology. 42(3_suppl). 675–675.
3.
Quintana, Melanie, Benjamin R. Saville, Michelle A. Detry, et al.. (2023). Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis. Annals of Neurology. 94(3). 547–560. 19 indexed citations
4.
Picozzi, Vincent J., Anne‐Marie Duliège, Eric A. Collisson, et al.. (2022). Precision Promise (PrP): An adaptive, multi-arm registration trial in metastatic pancreatic ductal adenocarcinoma (PDAC).. Journal of Clinical Oncology. 40(16_suppl). TPS4188–TPS4188. 6 indexed citations
5.
6.
Svedsäter, Henrik, Lucy Frith, David Leather, et al.. (2016). Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy. PubMed. 2(1). 4–4. 10 indexed citations
7.
Broglio, Kristine, Melanie Quintana, Eric S. Daar, et al.. (2014). Determining Comparative Effectiveness Benchmarks for Emerging Treatments for Hepatitis C Virus (Hcv) Infection in the Single Arm Study Design Setting. Value in Health. 17(3). A2–A2. 2 indexed citations
8.
Ward, Earlise, et al.. (2013). African American Men and Women’s Attitude Toward Mental Illness, Perceptions of Stigma, and Preferred Coping Behaviors. Nursing Research. 62(3). 185–194. 190 indexed citations
9.
Vardeny, Orly, et al.. (2012). β-AR Polymorphisms and Glycemic and Lipid Parameters in Hypertensive Individuals Receiving Carvedilol or Metoprolol. American Journal of Hypertension. 25(8). 920–926. 8 indexed citations
10.
Bedikian, Agop Y., Caimiao Wei, Michelle A. Detry, et al.. (2010). Predictive Factors for the Development of Brain Metastasis in Advanced Unresectable Metastatic Melanoma. American Journal of Clinical Oncology. 34(6). 603–610. 53 indexed citations
11.
Nakayama, Kazutaka, Ping Liu, Michelle A. Detry, et al.. (2009). Receiving Information on Fertility- and Menopause-Related Treatment Effects among Women Who Undergo Hematopoietic Stem Cell Transplantation: Changes in Perceived Importance Over Time. Biology of Blood and Marrow Transplantation. 15(11). 1465–1474. 32 indexed citations
12.
Vardeny, Orly, Michelle A. Detry, John J. Moran, Maryl R. Johnson, & Nancy K. Sweitzer. (2008). The β2 Adrenergic Receptor Gln27Glu Polymorphism Affects Insulin Resistance in Patients With Heart Failure: Possible Modulation by Choice of Beta Blocker. Journal of Cardiovascular Pharmacology. 52(6). 500–506. 10 indexed citations
13.
Hernández‐Valero, María A., Cynthia A. Thomson, Mike Hernández, et al.. (2008). Comparison of Baseline Dietary Intake of Hispanic and Matched Non-Hispanic White Breast Cancer Survivors Enrolled in the Women's Healthy Eating and Living Study. Journal of the American Dietetic Association. 108(8). 1323–1329. 9 indexed citations
14.
Vardeny, Orly, Nancy K. Sweitzer, Michelle A. Detry, et al.. (2008). Decreased Immune Responses to Influenza Vaccination in Patients With Heart Failure. Journal of Cardiac Failure. 15(4). 368–373. 37 indexed citations
15.
Kamat, Ashish M., Colin P. Dinney, Jason Gee, et al.. (2007). Micropapillary bladder cancer. Cancer. 110(1). 62–67. 187 indexed citations
16.
Smith, Chad, et al.. (2005). Cryopreserved Morulae can be used to Efficiently Generate Germline-transmitting Chimeras by Blastocyst Injection. Transgenic Research. 14(5). 685–690. 4 indexed citations
17.
Taylor, Wendell C., Wenyaw Chan, Sharon S. Cummings, et al.. (2002). Healthy Growth: project description and baseline findings.. PubMed. 12(4). 567–77. 13 indexed citations
18.
Vulimiri, Suryanarayana V., Xifeng Wu, Wanda Baer‐Dubowska, et al.. (2000). Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo- 2′-deoxyguanosine in lymphocyte DNA from a case–control study of lung cancer involving minority populations. Molecular Carcinogenesis. 27(1). 34–34. 10 indexed citations
19.
Spitz, M R, Cherie M. Duphorne, Michelle A. Detry, et al.. (2000). Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk.. PubMed. 9(10). 1017–20. 184 indexed citations
20.
Boone, William R., et al.. (1996). Sources of variation in measurements of carbon dioxide levels inside incubators. Journal of Assisted Reproduction and Genetics. 13(7). 606–608. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandros A. Drosos Breakdown of academic impact, for papers by Ching‐Chi Chi Breakdown of academic impact, for papers by Allan Gibofsky Breakdown of academic impact, for papers by Pekka Hannonen Breakdown of academic impact, for papers by Paraskevi V. Voulgari Breakdown of academic impact, for papers by César Ramos-Remus Breakdown of academic impact, for papers by Carol Hitchon Breakdown of academic impact, for papers by Grzegorz Mazur Breakdown of academic impact, for papers by Jill Waalen Breakdown of academic impact, for papers by M. H. van Rijswijk
Rankless by CCL
2026